Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead

We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Novavax, Inc. tops our list of the most ...
Reuters

Shah Capital intends to vote against Novavax's board nominees, executive compensation

April 8 (Reuters) - Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's (NVAX.O), opens new tab upcoming annual ...
The Daily Record (Maryland)

MD-based Novavax raises 2026 outlook on strength in vaccine deals

Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current regulatory ...
Seeking Alpha

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025. "In 2025, we ...
Hosted on MSN

Novavax Q4 earnings preview: Wall Street expects wider losses amid diversification efforts

In November, Novavax CEO John C. Jacobs detailed the company’s efforts beyond its COVID-19 vaccine, including expanding partnerships. In January, the company also entered into a license agreement with ...
The Business Journals

Investor calls for Novavax to slash costs, cut board as vaccine sales disappoint

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the third time in two years ...
Seeking Alpha

Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy

Management provided a 2026 adjusted total revenue target of $230 million to $270 million, including $35 million to $45 million of Nuvaxovid product sales under existing orders, $40 million to $50 ...